Enhancing Efficiency and Reach Using Facebook to Recruit Breast Cancer Survivors for a Telephone-Based Supportive Care Randomized Trial During the COVID-19 Pandemic.

Autor: Ejem DB; School of Nursing, University of Alabama at Birmingham, Birmingham, AL., Wechsler S; School of Health and Rehabilitation Sciences, Massachusetts General Hospital Institute of Health Professions, Boston, MA., Gallups S; School of Nursing, University of Alabama at Birmingham, Birmingham, AL., Khalidi S; School of Nursing, University of Alabama at Birmingham, Birmingham, AL., Coffee-Dunning J; School of Nursing, University of Alabama at Birmingham, Birmingham, AL., Montgomery AP; Department of Epidemiology, School of Public Health, University of Alabama at Birmingham, Birmingham, Al., Stevens CJ; Department of Psychiatry, Dartmouth-Hitchcock Health, Lebanon, NH., Keene K; Department of Radiation Oncology, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL., Rocque GB; Division of Geriatrics, Gerontology, and Palliative Care, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL.; Divisions of Hematology & Oncology, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL., Chamberlin M; Department of Hematology/Oncology, Dartmouth-Hitchcock Health, Lebanon, NH., Hegel MT; Department of Psychiatry, Dartmouth-Hitchcock Health, Lebanon, NH., Azuero A; School of Nursing, University of Alabama at Birmingham, Birmingham, AL., Pisu M; Division of Preventive Medicine, School of Medicine, University of Alabama at Birmingham, Birmingham, AL.; O'Neal Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL., Ellis D; Department of Psychiatry, Dartmouth-Hitchcock Health, Lebanon, NH., Ingram SA; Divisions of Hematology & Oncology, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL., Lawhon VM; Divisions of Hematology & Oncology, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL., Gilbert T; Department of Psychiatry, Dartmouth-Hitchcock Health, Lebanon, NH., Morrissette K; Department of Psychiatry, Dartmouth-Hitchcock Health, Lebanon, NH., Morency J; Department of Rehabilitation Medicine, Dartmouth-Hitchcock Medical Center, Lebanon, NH., Thorp K; Department of Rehabilitation Medicine, Dartmouth-Hitchcock Medical Center, Lebanon, NH., Codini M; Department of Rehabilitation Medicine, Dartmouth-Hitchcock Medical Center, Lebanon, NH., Newman R; College of Health and Rehabilitation Sciences, Boston University, Boston, MA., Echols J; School of Nursing, University of Alabama at Birmingham, Birmingham, AL., Cloyd D; School of Nursing, University of Alabama at Birmingham, Birmingham, AL., Dos Anjos S; School of Nursing, University of Alabama at Birmingham, Birmingham, AL.; Department of Occupational Therapy, School of Health Professions, University of Alabama at Birmingham, Birmingham, AL., Muse C; School of Health and Rehabilitation Sciences, Massachusetts General Hospital Institute of Health Professions, Boston, MA., Goedeken S; Department of Occupational Therapy, Massachusetts General Hospital, Boston, MA., Laws KE; School of Health and Rehabilitation Sciences, Massachusetts General Hospital Institute of Health Professions, Boston, MA., Herbert J; School of Health and Rehabilitation Sciences, Massachusetts General Hospital Institute of Health Professions, Boston, MA., Bakitas M; School of Nursing, University of Alabama at Birmingham, Birmingham, AL.; Division of Geriatrics, Gerontology, and Palliative Care, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL., Lyons KD; School of Health and Rehabilitation Sciences, Massachusetts General Hospital Institute of Health Professions, Boston, MA.

Publikováno v: JCO oncology practice [JCO Oncol Pract] 2023 Nov; Vol. 19 (11), pp. 1020-1030. Date of Electronic Publication: 2023 Sep 21.

Physician Perspectives on Reducing Curative Cancer Treatment Intensity for Populations Underrepresented in Clinical Trials.

Autor: Rocque GB; Division of Hematology and Oncology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA.; Division of Gerontology, Geriatrics, and Palliative Care, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA.; O'Neal Comprehensive Cancer Center, Birmingham, AL, USA., Andrews C; Institute for Human Rights, University of Alabama at Birmingham, Birmingham, AL, USA., Lawhon VM; Division of Hematology and Oncology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA., Ingram SA; Division of Hematology and Oncology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA., Frazier RM; Division of Hematology and Oncology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA., Smith ML; Research Advocacy Network, Plano, TX, USA., Wagner LI; Wake Forest School of Medicine, Winston Salem, NC, USA., Zubkoff L; O'Neal Comprehensive Cancer Center, Birmingham, AL, USA.; Division of Preventive Medicine, , Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA.; Birmingham/Atlanta Geriatric Research Education and Clinical Center (GRECC), Birmingham VA Healthcare System, Birmingham, AL, USA., Wallner LP; Rogel Cancer Center, Departments of Internal Medicine and Epidemiology, University of Michigan, Ann Arbor, MI, USA., Wolff AC; The Johns Hopkins University School of Medicine, Baltimore, MD, USA.

Publikováno v: The oncologist [Oncologist] 2022 Dec 09; Vol. 27 (12), pp. 1067-1073.

Patient perspectives on chemotherapy de-escalation in breast cancer.

Autor: Rocque GB; O'Neal Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL, USA.; Division of Hematology and Oncology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA.; Department of Medicine, Division of Geriatrics, Gerontology, and Palliative Care, University of Alabama at Birmingham, Birmingham, AL, USA., Williams CP; Division of Hematology and Oncology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA., Andrews C; UAB College of Arts and Sciences, School of Anthropology, University of Alabama at Birmingham, Birmingham, AL, USA., Childers TC; Division of Hematology and Oncology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA., Wiseman KD; Wake Forest School of Medicine, Winston-Salem, NC, USA., Gallagher K; Patient Advocate Foundation, Hampton, VA, USA., Tung N; Beth Israel Deaconess Medical Center, Boston, MA, USA., Balch A; Patient Advocate Foundation, Hampton, VA, USA., Lawhon VM; Division of Hematology and Oncology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA., Ingram SA; Division of Hematology and Oncology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA., Brown T; O'Neal Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL, USA., Kaufmann T; Dell Medical School, University of Texas at Austin LiveSTRONG Cancer Institute, Austin, TX, USA., Smith ML; ECOG-ACRIN Cancer Research Advocates Committee, Philadelphia, PA, USA., DeMichele A; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA., Wolff AC; John Hopkins University, Baltimore, MD, USA., Wagner L; Wake Forest School of Medicine, Winston-Salem, NC, USA.

Publikováno v: Cancer medicine [Cancer Med] 2021 May; Vol. 10 (10), pp. 3288-3298. Date of Electronic Publication: 2021 May 01.